ELI LILLY AND COMPANY Defined Benefit Plan, Amortization of Prior Service Cost (Credit)
ELI LILLY AND COMPANY (LLY) reported Defined Benefit Plan, Amortization of Prior Service Cost (Credit) of -$31.90 million for the 12-month period ending 2013-12-31, per its 10-K filed 2014-02-19.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit · last filed 2014-02-19
- ELI LILLY AND COMPANY defined benefit plan, amortization of prior service cost (credit) for the quarter ending 2010-09-30 was $1.70M, a 5.56% decline year-over-year.
- ELI LILLY AND COMPANY defined benefit plan, amortization of prior service cost (credit) for the quarter ending 2009-09-30 was $1.80M.
- ELI LILLY AND COMPANY defined benefit plan, amortization of prior service cost (credit) for fiscal 2013 was -$31.90M.
| Period end | Defined Benefit Plan, Amortization of Prior Service Cost (Credit) 3 month | Defined Benefit Plan, Amortization of Prior Service Cost (Credit) 9 month | Defined Benefit Plan, Amortization of Prior Service Cost (Credit) 12 month |
|---|---|---|---|
| 2013-12-31 | -$31.90M 10-K · filed 2014-02-19 | ||
| 2010-09-30 | $1.70M 10-Q · filed 2010-10-29 | $5.00M 10-Q · filed 2010-10-29 | |
| 2009-09-30 | $1.80M 10-Q · filed 2010-10-29 | $5.40M 10-Q · filed 2010-10-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Akari Therapeutics Plc (AKTX) | $1,527.991B | -47,921.42 | |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |